A clinical pharmacology and medical informatics professional from two Japanese universities recently analyzed potential adverse events associated with the COVID-19 mRNA-based vaccine called tozinameran—the Pfizer-BioNTech…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.